Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology; In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats-Reference-Cited by-同舟云学术

Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology; In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats

Published:2024-02-11 Issue: Volume: Page:
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Elkhayat Dalia¹^ORCID,Abdelmalak Nevine S.²,Amer Reham³,Awad Heba H.⁴

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), 26 July Mehwar Road intersection with Wahat Road, Sixth October City, Giza 12451, Egypt

2. Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt and School of pharmacy, New Giza University NGU, Giza 3296121, Egypt

3. Department of Pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, Al Azhar University Cairo, Cairo 4434003, Egypt

4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Sciences and Arts, Giza 12451, Egypt

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c08428

Reference47 articles.

1. Handelsman, Y.; Jellinger, P. S.; Guerin, C. K.AACE/ACE Consensus Statement CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM – 2020 EXECUTIVE SUMMARY. 2020, 26 (10), 1196–1224. 10.4158/CS-2020-0490.

2. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study

3. Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

4. Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product

5. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring Nanostructured Lipid Carriers for Efficient Delivery of Asenapine Maleate in Antipsychotic Treatment;2024-08-01

2. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10